WallStreetZenWallStreetZen

NASDAQ: OCS
Oculis Holding Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OCS

Based on 3 analysts offering 12 month price targets for Oculis Holding Ag

Min Forecast
$32.00+68.24%
Avg Forecast
$35.33+85.77%
Max Forecast
$41.00+115.56%

Should I buy or sell OCS stock?

Based on 3 analysts offering ratings for Oculis Holding Ag.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OCS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OCS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their OCS stock forecasts and price targets.

OCS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-04-17
lockedlocked$00.00+00.00%2025-03-13

1 of 1

Forecast return on equity

Is OCS forecast to generate an efficient return?

Company
-63.59%
Industry
140.91%
Market
90.47%
OCS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCS forecast to generate an efficient return on assets?

Company
-50.65%
Industry
32.45%
OCS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCS earnings per share forecast

What is OCS's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$2.44
Avg 2 year Forecast
-$2.44
Avg 3 year Forecast
-$3.55

OCS revenue forecast

What is OCS's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$817.0k-4.01%
Avg 2 year Forecast
$19.2M+2,157.22%
Avg 3 year Forecast
$50.7M+5,853.81%
OCS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OCS revenue growth forecast

How is OCS forecast to perform vs Biotechnology companies and vs the US market?

Company
271.79%
Industry
56.38%
Market
9.68%
OCS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OCS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OCS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCS$19.02$35.33+85.77%Strong Buy
SYRE$17.29$45.00+160.27%Buy
WVE$6.95$18.00+158.99%Strong Buy
NAGE$13.63$14.53+6.57%Strong Buy
ELVN$21.91$33.50+52.90%Strong Buy
View Top Biotech Stocks

Oculis Holding Ag Stock Forecast FAQ

Is Oculis Holding Ag Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: OCS) stock is to Strong Buy OCS stock.

Out of 3 analysts, 1 (33.33%) are recommending OCS as a Strong Buy, 2 (66.67%) are recommending OCS as a Buy, 0 (0%) are recommending OCS as a Hold, 0 (0%) are recommending OCS as a Sell, and 0 (0%) are recommending OCS as a Strong Sell.

If you're new to stock investing, here's how to buy Oculis Holding Ag stock.

What is OCS's earnings growth forecast for 2025-2027?

(NASDAQ: OCS) Oculis Holding Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Oculis Holding Ag's earnings in 2025 is -$125,484,146.On average, 5 Wall Street analysts forecast OCS's earnings for 2025 to be -$135,789,862, with the lowest OCS earnings forecast at -$157,236,215, and the highest OCS earnings forecast at -$106,120,555. On average, 5 Wall Street analysts forecast OCS's earnings for 2026 to be -$135,789,862, with the lowest OCS earnings forecast at -$187,794,490, and the highest OCS earnings forecast at -$93,897,245.

In 2027, OCS is forecast to generate -$197,239,775 in earnings, with the lowest earnings forecast at -$200,573,405 and the highest earnings forecast at -$193,906,145.

What is OCS's revenue growth forecast for 2025-2027?

(NASDAQ: OCS) Oculis Holding Ag's forecast annual revenue growth rate of 271.79% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Oculis Holding Ag's revenue in 2025 is $913,414.On average, 4 Wall Street analysts forecast OCS's revenue for 2025 to be $45,392,929, with the lowest OCS revenue forecast at $20,001,780, and the highest OCS revenue forecast at $60,560,945. On average, 4 Wall Street analysts forecast OCS's revenue for 2026 to be $1,067,428,326, with the lowest OCS revenue forecast at $40,003,560, and the highest OCS revenue forecast at $2,787,470,285.

In 2027, OCS is forecast to generate $2,815,528,338 in revenue, with the lowest revenue forecast at $2,633,012,095 and the highest revenue forecast at $2,998,044,580.

What is OCS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: OCS) forecast ROA is -50.65%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is OCS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OCS price target, the average OCS price target is $35.33, with the highest OCS stock price forecast at $41.00 and the lowest OCS stock price forecast at $32.00.

On average, Wall Street analysts predict that Oculis Holding Ag's share price could reach $35.33 by May 9, 2026. The average Oculis Holding Ag stock price prediction forecasts a potential upside of 85.77% from the current OCS share price of $19.02.

What is OCS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OCS) Oculis Holding Ag's current Earnings Per Share (EPS) is -$2.88. On average, analysts forecast that OCS's EPS will be -$2.44 for 2025, with the lowest EPS forecast at -$2.83, and the highest EPS forecast at -$1.91. On average, analysts forecast that OCS's EPS will be -$2.44 for 2026, with the lowest EPS forecast at -$3.38, and the highest EPS forecast at -$1.69. In 2027, OCS's EPS is forecast to hit -$3.55 (min: -$3.61, max: -$3.49).

What is OCS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: OCS) forecast ROE is -63.59%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.